Who Can Be Blinded in a Study: Participants, Clinicians, Data Collectors, Outcome Assessors, or Analysts?

Who Actually Needs to Be Unaware of Treatment Assignment?

You are designing a study comparing an intervention with a control condition. Participants may recognize which intervention they receive, particularly if it involves a new teaching approach, digital learning platform, or clinical procedure. Does that mean the study cannot use blinding at all?

What about the people delivering the intervention, collecting questionnaires, assessing outcomes, managing the dataset, or conducting the statistical analysis? Could some remain unaware of treatment assignments even when others cannot?

These questions matter because different people can influence different stages of a study. Describing a trial as simply blinded or unblinded may conceal important distinctions about where bias could arise and which safeguards are feasible.

Several Research Roles Can Be Blinded Independently

Understanding the Different Roles That Can Be Blinded

Blinding Concerns Information, Not Merely Job Titles

Blinding, also called masking, involves withholding information about assigned interventions or other study characteristics from individuals whose knowledge could influence study conduct, outcome measurement, or interpretation.

Although treatment assignment is the most familiar information concealed, researchers may also mask intervention identities, hypotheses, assessment results, or group labels when doing so serves a legitimate methodological purpose.

Not everyone requires the same information. A clinician responsible for treatment safety may need access to information that an independent outcome assessor does not. A statistical analyst may work with coded groups while an intervention provider necessarily knows which treatment is being delivered.

The purpose of blinding in research is to reduce particular opportunities for bias. It is not to achieve the largest possible number of blinded people.

Can Participants Be Blinded?

Participants can be blinded when they cannot reliably distinguish their assigned condition from the comparison condition.

In some medication trials, visually similar preparations and comparable administration procedures may support participant blinding. In other studies, an appropriately designed sham procedure or comparison intervention may serve a similar purpose, provided ethical requirements are satisfied.

Participant blinding may reduce differences in expectations, reporting, treatment-seeking behavior, or adherence that arise from knowing the assigned condition.

It is especially relevant when outcomes depend substantially on participants' subjective reports.

However, participant blinding is frequently impractical in educational, behavioral, rehabilitation, and organizational interventions. Students may know whether they are using an adaptive learning platform, and teachers may recognize the instructional approach being implemented.

The inability to blind participants does not automatically invalidate the study. Researchers should instead consider when participant blinding is impossible and which alternative safeguards can reduce bias.

Can Clinicians or Intervention Providers Be Blinded?

Clinicians, teachers, therapists, facilitators, and other intervention providers may be blinded when treatment conditions can be delivered without revealing their identity.

For example, a clinician administering identically packaged treatments might remain unaware of the allocation code.

By contrast, a teacher delivering a particular instructional strategy usually needs to know what the strategy involves. A therapist providing a distinctive rehabilitation technique may similarly recognize the treatment.

Provider blinding can reduce differences in enthusiasm, additional support, treatment decisions, or communication that might otherwise depend on knowledge of assignment.

Where provider blinding is infeasible, researchers can use standardized protocols, provider training, documented intervention delivery, and appropriate separation of provider and assessment responsibilities.

These safeguards may reduce bias but do not necessarily reproduce the protection offered by successful blinding.

Can Data Collectors Be Blinded?

Yes. Data collectors may be kept unaware of treatment assignments, particularly when their responsibilities involve administering assessments or obtaining information directly from participants.

For example, a research assistant administering a standardized achievement test may not need to know whether the student received the experimental instructional intervention.

Blinding may reduce the possibility that data collectors provide different instructions, prompts, encouragement, or follow-up effort according to treatment group.

However, data collection and outcome assessment are not always separate activities. A data collector may simply retrieve automatically recorded information, or may also exercise judgment in evaluating participants.

Researchers should identify the actual tasks performed rather than assume that blinding someone designated as a data collector addresses every assessment-related bias.

Can Outcome Assessors Be Blinded?

Yes, and outcome-assessor blinding may be particularly valuable when assessment requires human judgment.

An outcome assessor determines or evaluates the outcome used in the analysis. This person might rate a clinical condition, score a performance task, classify an event, or evaluate the quality of student work.

If the assessor knows the participant's treatment assignment, that knowledge could influence judgments, especially when the assessment criteria allow interpretation.

For example, an assessor evaluating the quality of research proposals may be influenced by knowing which students received a specialized writing intervention.

Removing participant identifiers and treatment information from submitted work may allow independent assessors to apply the same rubric without knowing group assignments.

The value of outcome-assessor blinding depends partly on the outcome's susceptibility to assessment-related bias.

Can Data Managers Be Blinded?

Sometimes. Data managers may work with coded treatment groups rather than recognizable intervention labels.

For example, a dataset might identify treatment groups as A and B while the allocation key is maintained separately by an authorized individual.

Such arrangements can reduce opportunities for treatment-aware decisions during data cleaning, variable coding, or preparation of analysis datasets.

However, some data-management responsibilities require knowledge of allocation, particularly when resolving treatment-specific data queries or maintaining randomization records.

Access should therefore be determined by operational necessity. A restricted allocation key, documented permissions, and an audit trail may be more useful than claiming that the entire data-management team was blinded.

Can Statistical Analysts Be Blinded?

Yes. Statistical analysts can sometimes conduct prespecified analyses using coded treatment groups without knowing which code represents the experimental intervention.

For example, an analyst may compare groups A and B, examine model assumptions, and prepare results while an independent individual retains the allocation key.

This arrangement may reduce the risk that knowledge of treatment identity influences analytical decisions.

However, coded labels do not always guarantee meaningful blinding. Treatment identity may be apparent from intervention-specific variables, distinctive outcome patterns, or other dataset characteristics.

Furthermore, some analyses require treatment-specific knowledge to address protocol deviations, adverse events, or particular estimands.

The feasibility and value of blinding statistical analysts should therefore be considered alongside prespecified analysis plans and transparent analytical procedures.

Can Different Research Roles Be Blinded Independently?

Yes. A study may have unblinded participants and providers but blinded outcome assessors and analysts.

Consider an educational trial in which teachers deliver a new instructional approach. Teachers and students necessarily know what instruction they are receiving. Nevertheless, examination scripts can be anonymized and scored by assessors who do not know the students' assignments.

The statistical analyst might also receive coded group labels.

This design does not achieve participant or provider blinding, but it can reduce certain opportunities for outcome assessment and analysis bias.

The distinction is more informative than simply describing the study as unblinded.

Which Roles Can Be Blinded, and What Biases Might This Address?

The table identifies potential protections, not guaranteed effects. The importance of each role depends on the actual study procedures and the opportunities for bias.

Why Are Single-, Double-, and Triple-Blind Labels Insufficient?

Traditional labels such as single-blind and double-blind are widely used but can be ambiguous.

For example, double-blind might refer to participants and clinicians in one report, but participants and outcome assessors in another.

Consequently, these labels do not reliably identify which individuals were unaware of treatment assignment.

CONSORT reporting guidance emphasizes describing who was blinded and how blinding was achieved.

Researchers should therefore identify each relevant role explicitly rather than rely on single-, double-, or triple-blind terminology as a substitute for methodological detail.

Is Blinding the Same as Allocation Concealment?

No. Allocation concealment and blinding address different stages and risks of bias.

A study can use proper allocation concealment even when participants and providers cannot be blinded after assignment.

Conversely, apparently similar treatment conditions do not compensate for a predictable or inadequately concealed allocation sequence.

Both safeguards should be planned and reported separately.

Does Blinding Matter for Objectively Measured Outcomes?

It may, although the relevant risks differ.

An automatically recorded laboratory value may be less susceptible to assessor interpretation than a subjective rating. Nevertheless, knowledge of assignment can influence whether an outcome is measured, when it is measured, how missing observations are handled, or which additional care participants receive.

Thus, blinding for objectively measured outcomes should be evaluated according to the entire outcome-generation and measurement process, not merely the apparent objectivity of the final number.

What Happens When Blinding Cannot Be Maintained?

Blinding may be compromised when participants recognize distinctive intervention features, experience revealing side effects, or encounter information that identifies their assigned condition.

Researchers should anticipate plausible disclosure pathways and establish procedures for maintaining blinding where feasible.

When unblinding is necessary for safety or another legitimate reason, the process should follow the protocol and be documented.

The implications of blinding failure depend on who became unblinded, when it occurred, and how that knowledge could influence the outcome or analysis.

How Should Blinding Be Documented?

The protocol should specify which roles are intended to be blinded, what information will be concealed, who controls access to allocation information, and when unblinding is permitted.

Researchers should describe the practical mechanisms used, such as coded treatment labels, independent assessors, masked materials, or restricted allocation records.

The final report should distinguish intended blinding from what actually occurred.

When blinding was not feasible, the report should explain the limitation and describe safeguards used to reduce the resulting risks of bias.

Reporting the arrangement transparently allows readers to evaluate the study's internal validity more meaningfully than a generic blinding label.

Blinding Different Roles in an Educational Technology Trial

The study is not fully blinded. Nevertheless, the design separates intervention delivery from outcome assessment and reduces some opportunities for treatment-aware decisions.

It would be inaccurate to claim that these safeguards eliminate expectation effects or differential participant behavior. Their value lies in addressing specific sources of potential bias while acknowledging those that remain.

Common Misconceptions About Who Can Be Blinded

Plan Blinding by Role and Risk of Bias

Begin by mapping who will interact with participants, deliver interventions, collect information, assess outcomes, manage data, and conduct analyses.

For each role, determine whether knowledge of treatment assignment is necessary and how that knowledge could influence the study.

For studies where participant and provider blinding cannot be implemented, consider design strategies that minimize bias without blinding.

The objective is to establish a credible arrangement in which each person receives the information needed to perform their responsibilities without unnecessarily exposing the study to allocation-related influence.

Before Finalizing Who Will Be Blinded

Frequently Asked Questions About Blinding Research Roles

Blinding Should Be Planned for Each Role, Not Assigned One Label

How to Cite This Guide

This guide is intended to be read, shared, and used in research, teaching, and academic work. If you draw on its ideas, explanations, or other content, please acknowledge the source by citing the guide. Doing so gives appropriate credit and helps your readers locate the original resource.